Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Richard Morter


Postdoctoral immunologist


I completed my DPhil at the Jenner Institute in 2019, supervised by Prof Katie Ewer and Prof Adrian Hill. Part of my project was also undertaken at the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya supervised by Prof Philip Bejon. My studies were supported by a studentship from the Wellcome Trust through the Infection Immunology and Translational Medicine programme.


My project investigated differences in immune responses to an experimental malaria vaccine (ChAd63 / MVA ME-TRAP) between malaria-naïve and malaria-exposed individuals. In particular I was interested in the effect Regulatory T cells (Tregs) had on immune responses to vaccines. I also investigated the role of Tregs in the immune response to controlled human malaria infection (CHMI) as part of a larger study being undertaken in Kilifi. During my DPhil I was also involved in primary analyses of immune responses to experimental vaccines for both malaria and Ebola in clinical trials.


I am now a medical student on a fast-track programme at the University of Warwick, supported by a Foulkes Foundation Fellowship. In April 2020 I returned to the Jenner Institute to support the initial clinical trials for the Oxford COVID-19 vaccine. I was mostly involved with a large team assessing T cell responses to vaccination and was responsible for running and analysing flow cytometry experiments and supervised reading ELISPOT plates. I continue to assist with data analysis and writing manuscripts for the trials, alongside my medical studies.


I am interested in many aspects of infectious diseases, global health and cellular immunology and am looking to pursue these interests both clinically and academically in the future.